xylazine has been researched along with Chronic Disease in 4 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypernatremia increases the speed of transition from different steps of ketamine/xylazine anesthesia with significant delay in immobility period and recovery from anesthesia in rats, hence, anesthetic dose reduction in hypernatremia is necessary." | 7.74 | Determination of sensitivity of male Wistar rats to an equal dose of ketamine/xylazine injection at anesthetic dose in a chronic model of hypernatremia in comparison with control group. ( Amini, B; Heydarpour, F; Heydarpour, P; Kalantari, S; Rostami, A, 2007) |
| "A comparison of the analgesic potency of the alpha 2-adrenoceptor agonist, xylazine, in control healthy sheep and sheep suffering chronic pain from footrot, indicated that the analgesic effectiveness of xylazine was significantly reduced in the animals experiencing chronic pain." | 7.68 | The influence of chronic pain on the analgesic effects of the alpha 2-adrenoceptor agonist, xylazine, in sheep. ( Ley, S; Livingston, A; Waterman, A, 1991) |
| "Hypernatremia increases the speed of transition from different steps of ketamine/xylazine anesthesia with significant delay in immobility period and recovery from anesthesia in rats, hence, anesthetic dose reduction in hypernatremia is necessary." | 3.74 | Determination of sensitivity of male Wistar rats to an equal dose of ketamine/xylazine injection at anesthetic dose in a chronic model of hypernatremia in comparison with control group. ( Amini, B; Heydarpour, F; Heydarpour, P; Kalantari, S; Rostami, A, 2007) |
| "A comparison of the analgesic potency of the alpha 2-adrenoceptor agonist, xylazine, in control healthy sheep and sheep suffering chronic pain from footrot, indicated that the analgesic effectiveness of xylazine was significantly reduced in the animals experiencing chronic pain." | 3.68 | The influence of chronic pain on the analgesic effects of the alpha 2-adrenoceptor agonist, xylazine, in sheep. ( Ley, S; Livingston, A; Waterman, A, 1991) |
| "Xylazine sedation was not associated with changes in pulmonary function but did result in markedly decreased REE in controls." | 1.32 | Energetic cost of breathing, body composition, and pulmonary function in horses with recurrent airway obstruction. ( Bedenice, D; Deveney, EF; DeWitt, S; Hoffman, A; Mazan, MR, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazan, MR | 1 |
| Deveney, EF | 1 |
| DeWitt, S | 1 |
| Bedenice, D | 1 |
| Hoffman, A | 1 |
| Heydarpour, F | 1 |
| Amini, B | 1 |
| Kalantari, S | 1 |
| Rostami, A | 1 |
| Heydarpour, P | 1 |
| Herholz, C | 1 |
| Tschudi, P | 1 |
| Gerber, H | 1 |
| Moens, Y | 1 |
| Straub, R | 1 |
| Ley, S | 1 |
| Waterman, A | 1 |
| Livingston, A | 1 |
4 other studies available for xylazine and Chronic Disease
| Article | Year |
|---|---|
Energetic cost of breathing, body composition, and pulmonary function in horses with recurrent airway obstruction.
Topics: Adrenergic alpha-Agonists; Aerosols; Airway Obstruction; Animals; Body Composition; Bronchodilator A | 2004 |
Determination of sensitivity of male Wistar rats to an equal dose of ketamine/xylazine injection at anesthetic dose in a chronic model of hypernatremia in comparison with control group.
Topics: Adrenergic alpha-Agonists; Anesthesia; Anesthetics, Dissociative; Animals; Chronic Disease; Disease | 2007 |
Ultrasound spirometry in the horse: a preliminary report on the method and the effects of xylazine and lobeline hydrochloride medication.
Topics: Animals; Bronchiolitis; Chronic Disease; Horse Diseases; Horses; Lobeline; Lung; Reference Values; R | 1997 |
The influence of chronic pain on the analgesic effects of the alpha 2-adrenoceptor agonist, xylazine, in sheep.
Topics: Analgesia; Animals; Chronic Disease; Female; Foot Rot; Pain; Pain Measurement; Sensory Thresholds; S | 1991 |